The Atmo Gas Sensing Capsule shows strong potential as a replacement for Medtronic’s discontinued SmartPill, achieving over 84% agreement in measuring transit times for gastrointestinal motility disorders. A study involving 209 patients highlighted its reliability in detecting gastric emptying and colonic transit times. The capsule’s extended battery life (10 days vs. 5 days) and capability to identify multi-regional dysmotility in 18% of cases make it a valuable diagnostic tool. No serious adverse effects were reported, underscoring its safety and utility for assessing complex GI conditions.
Atmo capsule may offer ‘potential replacement’ for nixed SmartPill in motility disorders (Healio)
0